Sandu Pharmaceuticals Announces Trading Window Closure
Sandu Pharmaceuticals Ltd. announced the closure of its trading window for Directors, Key Managerial Personnel (KMPs), Promoters, Promoter Group, and Designated Persons, as well as their immediate relatives. The closure, in accordance with the company’s Code of Conduct for Prevention of Insider Trading and SEBI (Prohibition of Insider Trading) Regulations, 2015, began on Wednesday, April 1, 2026.The trading window will remain closed for 48 hours following the announcement of the company’s financial results for the quarter and year ended March 31, 2026. The date for the Board Meeting to consider these financial results will be communicated at a later date.
During the closure period, designated individuals and their immediate relatives are restricted from trading in the company’s securities. Sandu Pharmaceuticals' stock trades under the code 524703 on the Bombay Stock Exchange.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.